$4.01
-0.415[-9.38%]
At close: Apr 19
$4.01
0[0.00%]
After Hours: 8:49AM EDT
Marker Therapeutics
(NASDAQ:MRKR)Latest News for Marker Therapeutics Stock (NASDAQ:MRKR)
Marker Therapeutics Stock (NASDAQ: MRKR)
Categories: All
Monday, March 25, 2024
Monday, January 08, 2024
- Cancer Cell Therapy Focused Marker Therapeutics Announces Pipeline PrioritizationVandana Singh - Jan 8, 2024, 7:31AM
- Marker Therapeutics Says 'MultiTAA-specific T cell therapies demonstrate clinical safety and positive clinical data across multiple indications'Benzinga Newsdesk - Jan 8, 2024, 7:30AM
- Marker Therapeutics Says 'Strategic prioritization of clinical programs with focus on MT-601 in patients with lymphoma'Benzinga Newsdesk - Jan 8, 2024, 7:30AM
- Marker Therapeutics Announces Clinical Program Updates And Pipeline PrioritizationBenzinga Newsdesk - Jan 8, 2024, 7:29AM
Friday, December 29, 2023
Monday, December 11, 2023
- 12 Health Care Stocks Moving In Monday's Intraday SessionBenzinga Insights - Dec 11, 2023, 12:30PM
- Marker Therapeutics shares are trading higher after the company reported a clinical update on the APOLLO study.Benzinga Newsdesk - Dec 11, 2023, 12:25PM
- Marker Therapeutics Announces Sustained Complete Response in First Lymphoma Patient Treated with MT-601 following CAR T RelapseBenzinga Newsdesk - Dec 11, 2023, 7:04AM
Thursday, November 09, 2023
Monday, September 11, 2023
- Why Is Blood Cancer Focused Marker Therapeutics Stock Trading Higher Today?Vandana Singh - Sep 11, 2023, 1:46PM
- Why Avantax Shares Are Trading Higher By Over 27%? Here Are Other Stocks Moving In Monday's Mid-Day SessionLisa Levin - Sep 11, 2023, 1:38PM
- Marker Therapeutics Announced The Preliminary Results Of The First Participant Treated With MT-601, Its Multi-tumor Associated Antigen-specific T Cell Product Targeting 6 Taas, In The Phase 1 Multicenter APOLLO TrialBenzinga Newsdesk - Sep 11, 2023, 7:04AM
Tuesday, August 15, 2023
Monday, August 14, 2023
Monday, July 31, 2023
Friday, July 28, 2023
Monday, July 24, 2023
Tuesday, July 18, 2023
Tuesday, July 11, 2023
Monday, July 10, 2023
- Why Icahn Enterprises Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Monday's Mid-Day SessionLisa Levin - Jul 10, 2023, 12:34PM
- Why Marker Therapeutics (MRKR) Stock Is Trading Sharply HigherHenry Khederian - Jul 10, 2023, 11:28AM
- Marker Therapeutics shares are trading higher after the company announced the European Medicines Agency granted MT-401 an Orphan Drug Designation.Benzinga Newsdesk - Jul 10, 2023, 10:49AM
- Marker Therapeutics Says European Medicines Agency Granted Orphan Drug Designation For MT-401 For Treatment Of AML PatientsBenzinga Newsdesk - Jul 10, 2023, 7:08AM
Tuesday, June 13, 2023
Monday, June 12, 2023
- Nasdaq Gains 1%; US Budget Deficit Widens In MayLisa Levin - Jun 12, 2023, 2:54PM
- Why Asset Entities Shares Are Trading Higher By 142%? Here Are Other Stocks Moving In Monday's Mid-Day SessionLisa Levin - Jun 12, 2023, 1:03PM
- Crude Oil Drops Sharply; Chinook Therapeutics Shares Spike HigherLisa Levin - Jun 12, 2023, 12:05PM
- Marker Therapeutics shares are trading higher after it reported first patient was treated in the company's Phase 1 APOLLO trial of MT-601 for lymphoma patients.Benzinga Newsdesk - Jun 12, 2023, 10:06AM
- Marker Therapeutics Announces First Lymphoma Patient Treated With MT-601 In Phase 1 Clinical TrialBenzinga Newsdesk - Jun 12, 2023, 7:04AM
Friday, June 09, 2023
- Why American Software Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Friday's Mid-Day SessionLisa Levin - Jun 9, 2023, 12:49PM
- Director of Marker Therapeutics Makes $249K BuyBenzinga Insights - Jun 9, 2023, 11:06AM
- Marker Therapeutics Director Awarded $19K Worth of Stock OptionsBenzinga Insights - Jun 9, 2023, 11:01AM
- Board Member at Marker Therapeutics Acquires Company Stock Options Worth 8,000 SharesBenzinga Insights - Jun 9, 2023, 11:01AM
Monday, June 05, 2023
Wednesday, May 31, 2023
- Crude Oil Down 2%; Donaldson Shares Drop Following Q3 ResultsLisa Levin - May 31, 2023, 2:39PM
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga Insights - May 31, 2023, 1:31PM
- Why Capri Holdings Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionLisa Levin - May 31, 2023, 1:01PM
- Nasdaq Down 100 Points; Advance Auto Parts Earnings Miss ViewsLisa Levin - May 31, 2023, 12:06PM
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga Insights - May 31, 2023, 9:06AM
- High-Impact Movers for May 31stBenzinga Newsdesk - May 31, 2023, 8:50AM
- Marker Therapeutics shares are trading higher after the company reported pre-clinical data of its MT-601 multiTAA-specific T cell product candidate MT-601 in lymphoma cells.Benzinga Newsdesk - May 31, 2023, 8:22AM
- Marker Therapeutics Reports Pre-Clinical Data Of MT-601 MultiTAA-Specific T Cell Product Candidate In Lymphoma CellsBenzinga Newsdesk - May 31, 2023, 6:35AM
Thursday, May 04, 2023
Monday, May 01, 2023
- Marker Therapeutics shares are trading higher after the company announced an agreement with CellReady, under which the company will sell certain cell manufacturing assets to CellReady for roughly $19 million in cash.Benzinga Newsdesk - May 1, 2023, 10:23AM
- 12 Health Care Stocks Moving In Monday's Pre-Market SessionBenzinga Insights - May 1, 2023, 9:06AM